Clinical Trial Update: Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan [Phase 2]

View source ↗

Summary

Phase II trial evaluating bevacizumab with temozolomide or etoposide in glioblastoma or gliosarcoma patients who progressed after bevacizumab plus irinotecan; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Gliosarcoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• Etoposide (Etoposide)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Duke University | Conditions: Glioblastoma, Gliosarcoma | Phase 2 | Status: COMPLETED | Results posted: 2013-02-04